Gene · 200315
Papers1,983
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,983
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Efficient CRISPR-mediated C-to-T base editing in Komagataella phaffii. | Biotechnol J | 2024 | 38987223 | PubTator, text mining | PubMed |
| Hypomorphic mutation in the large subunit of replication protein A affects mutagenesis by human APOBEC cytidine deaminases in yeast. | bioRxiv | 2024 | 38979205 | PubTator, text mining | PubMed |
| The cytidine deaminase APOBEC3A regulates nucleolar function to promote cell growth and ribosome biogenesis. | PLoS Biol | 2024 | 38976757 | PubTator, text mining | PubMed |
| Simultaneous detection of 5-methylcytosine and 5-hydroxymethylcytosine at specific genomic loci by engineered deaminase-assisted sequencing. | Chem Sci | 2024 | 38966352 | PubTator, text mining | PubMed |
| The role of distinct APOBEC/ADAR mRNA levels in mutational signatures linked to aging and ultraviolet radiation. | Sci Rep | 2024 | 38965255 | PubTator, text mining | PubMed |
| The cytidine deaminase APOBEC3C has unique sequence and genome feature preferences. | Genetics | 2024 | 38946641 | PubTator, text mining | PubMed |
| The SMC5/6 complex prevents genotoxicity upon APOBEC3A-mediated replication stress. | EMBO J | 2024 | 38886582 | PubTator, text mining | PubMed |
| nCas9 Engineering for Improved Target Interaction Presents an Effective Strategy to Enhance Base Editing. | Adv Sci (Weinh) | 2024 | 38881503 | PubTator, text mining | PubMed |
| APOBEC3-related mutations in the spike protein-encoding region facilitate SARS-CoV-2 evolution. | Heliyon | 2024 | 38868014 | PubTator, text mining | PubMed |
| DNA mismatch and damage patterns revealed by single-molecule sequencing. | Nature | 2024 | 38867045 | PubTator, text mining | PubMed |
| Her2 amplification, Rel-A, and Bach1 can influence APOBEC3A expression in breast cancer cells. | PLoS Genet | 2024 | 38805570 | PubTator, text mining | PubMed |
| Induction of the antiviral factors APOBEC3A and RSAD2 upon CCL2 neutralization in primary human macrophages involves NF-κB, JAK/STAT, and gp130 signaling. | J Leukoc Biol | 2024 | 38798090 | PubTator, text mining | PubMed |
| Synthesis of 1,4-azaphosphinine nucleosides and evaluation as inhibitors of human cytidine deaminase and APOBEC3A. | Beilstein J Org Chem | 2024 | 38774272 | PubTator, text mining | PubMed |
| RNA editing in host lncRNAs as potential modulator in SARS-CoV-2 variants-host immune response dynamics. | iScience | 2024 | 38770134 | PubTator, text mining | PubMed |
| Development of Allosteric Small Molecule APOBEC3B Inhibitors from In Silico Screening. | bioRxiv | 2024 | 38712210 | PubTator, text mining | PubMed |
| The implications of APOBEC3-mediated C-to-U RNA editing for human disease. | Commun Biol | 2024 | 38704509 | PubTator, text mining | PubMed |
| Inhibition of caspase pathways limits CD4+ T cell loss and restores host anti-retroviral function in HIV-1 infected humanized mice with augmented lymphoid tissue. | Retrovirology | 2024 | 38693565 | PubTator, text mining | PubMed |
| Engineering APOBEC3A deaminase for highly accurate and efficient base editing. | Nat Chem Biol | 2024 | 38553609 | PubTator, text mining | PubMed |
| Distinguishing preferences of human APOBEC3A and APOBEC3B for cytosines in hairpin loops, and reflection of these preferences in APOBEC-signature cancer genome mutations. | Nat Commun | 2024 | 38499553 | PubTator, text mining | PubMed |
| Mesoscale DNA features impact APOBEC3A and APOBEC3B deaminase activity and shape tumor mutational landscapes. | Nat Commun | 2024 | 38499542 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/200315/papers?page=6